上海医药(02607)：戊二酸利那拉生酯胶囊(X842 项目)上市许可申请获得批准Yixin Group (02858) achieved significant growth in the fintech business with a total financing of 18.5 billion yuan in the third quarter; China Xinlianxin Chemical Fertilizer (01866): 0.06 million ton polyformaldehyde project has been completed and has entered the trial production stage
Important matters:
Federal Pharmaceuticals (03933) approved for marketing the anti-infective product mupirocin ointment
Shanghai Pharmaceutical (02607): Linalacene glutarate capsule (X842 project) marketing license application approved
China Heart Link Chemical Fertilizer (01866): The 0.06 million ton polyformaldehyde project has been completed and has entered the trial production stage
Shangtang-W (00020): Complete strategic organizational restructuring
Yuexiu Real Estate (00123): Plans to sell all shares in Guangzhou Hongcheng Development for 1.092 billion yuan
Meitu (01357) has sold all of its cryptocurrency holdings for a profit of about $79.63 million
Yongli Investment (01145) received a discount of about 8.83% from Huajian Co., Ltd. and offered a full purchase offer to resume trading on December 5
Operating performance:
Yixin Group (02858)'s total financing in the third quarter reached 18.5 billion yuan, and the fintech business achieved significant growth
Country Garden (02007) achieved contract sales of about 3.01 billion yuan in November belonging to the company's shareholders' rights
Xinli International (00732)'s cumulative consolidated net turnover for the first 11 months was approximately HK$16.263 billion, up about 16.0% year over year
Jingrui Holdings (01862)'s cumulative contract sales for the first 11 months were 1.91 billion yuan, a year-on-year decrease of 46.41%
For more details, please refer to Zhitong Financial Network ()
